BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Poupon L, Kerckhove N, Vein J, Lamoine S, Authier N, Busserolles J, Balayssac D. Minimizing chemotherapy-induced peripheral neuropathy: preclinical and clinical development of new perspectives. Expert Opinion on Drug Safety 2015;14:1269-82. [DOI: 10.1517/14740338.2015.1056777] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Le Gouill-Jaijarat C, Péréon Y, Leroy M, Lépine O, Loloum A, Peluchon C, Volteau C, Martineau AS, Korner S, Perrault C, Benmaziane A, Girot P, Petorin C, Perret C, Ligeza-Poisson C, Mayeur D, Flet L, Chiffoleau A, Poinas A, Bennouna J. PROPERTY: study protocol for a randomized, double-blind, multicenter placebo-controlled trial assessing neurotoxicity in patients with metastatic gastrointestinal cancer taking PHYCOCARE® during oxaliplatin-based chemotherapy. Trials 2023;24:50. [PMID: 36670495 DOI: 10.1186/s13063-023-07071-z] [Reference Citation Analysis]
2 Chai Y, Zhao F, Ye P, Ma F, Wang J, Zhang P, Li Q, Wang J, Wang W, Li Q, Xu B. A Prospective, Randomized, Placebo-Controlled Study Assessing the Efficacy of Chinese Herbal Medicine (Huangqi Guizhi Wuwu Decoction) in the Treatment of Albumin-Bound Paclitaxel-Induced Peripheral Neuropathy. J Clin Med 2023;12. [PMID: 36675434 DOI: 10.3390/jcm12020505] [Reference Citation Analysis]
3 Lv X, Mao Y, Cao S, Feng Y. Animal models of chemotherapy‐induced peripheral neuropathy for hematological malignancies: A review. Ibrain 2022. [DOI: 10.1002/ibra.12086] [Reference Citation Analysis]
4 Yang Y, Zhao B, Gao X, Sun J, Ye J, Li J, Cao P. Targeting strategies for oxaliplatin-induced peripheral neuropathy: clinical syndrome, molecular basis, and drug development. J Exp Clin Cancer Res 2021;40:331. [PMID: 34686205 DOI: 10.1186/s13046-021-02141-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
5 Gu Z, Wei G, Zhu L, Zhu L, Hu J, Li Q, Cai G, Lu H, Liu M, Chen C, Ji Y, Li G, Huo J. Preventive Efficacy and Safety of Yiqi-Wenjing-Fang Granules on Oxaliplatin-Induced Peripheral Neuropathy: A Protocol for a Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial. Evid Based Complement Alternat Med 2021;2021:5551568. [PMID: 34630609 DOI: 10.1155/2021/5551568] [Reference Citation Analysis]
6 Toma W, Caillaud M, Patel NH, Tran TH, Donvito G, Roberts J, Bagdas D, Jackson A, Lichtman A, Gewirtz DA, Makriyannis A, Malamas MS, Imad Damaj M. N-acylethanolamine-hydrolysing acid amidase: A new potential target to treat paclitaxel-induced neuropathy. Eur J Pain 2021;25:1367-80. [PMID: 33675555 DOI: 10.1002/ejp.1758] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
7 Hardy-Bessard AC, Brocard F, Clatot F, Lortholary A, You B, Grenier J, Martin-Babau J, Lucas B, Meunier J, Ferrero JM, Savoye AM, Marti A, Despax R, Moullet I, Emile G. First-line bevacizumab and eribulin combination therapy for HER2-negative metastatic breast cancer: Efficacy and safety in the GINECO phase II ESMERALDA study. Breast 2020;54:256-63. [PMID: 33188992 DOI: 10.1016/j.breast.2020.09.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
8 Chien TJ, Liu CY, Fang CJ, Kuo CY. The Efficacy of Acupuncture in Chemotherapy-Induced Peripheral Neuropathy: Systematic Review and Meta-Analysis. Integr Cancer Ther 2019;18:1534735419886662. [PMID: 31833790 DOI: 10.1177/1534735419886662] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 7.3] [Reference Citation Analysis]
9 Geohagen BC, Weiser DA, Loeb DM, Nordstroem LU, LoPachin RM. Enolate-forming compounds provide protection from platinum neurotoxicity. Chem Biol Interact 2020;317:108961. [PMID: 31978392 DOI: 10.1016/j.cbi.2020.108961] [Reference Citation Analysis]
10 Sałat K. Chemotherapy-induced peripheral neuropathy-part 2: focus on the prevention of oxaliplatin-induced neurotoxicity. Pharmacol Rep 2020;72:508-27. [PMID: 32347537 DOI: 10.1007/s43440-020-00106-1] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 10.3] [Reference Citation Analysis]
11 Larson CM, Wilcox GL, Fairbanks CA. The Study of Pain in Rats and Mice. Comp Med 2019;69:555-70. [PMID: 31822322 DOI: 10.30802/AALAS-CM-19-000062] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
12 Kerckhove N, Boudieu L, Ourties G, Bourdier J, Daulhac L, Eschalier A, Mallet C. Ethosuximide improves chronic pain-induced anxiety- and depression-like behaviors. Eur Neuropsychopharmacol 2019;29:1419-32. [PMID: 31767519 DOI: 10.1016/j.euroneuro.2019.10.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
13 Andersen Hammond E, Pitz M, Shay B. Neuropathic Pain in Taxane-Induced Peripheral Neuropathy: Evidence for Exercise in Treatment. Neurorehabil Neural Repair. 2019;33:792-799. [PMID: 31342880 DOI: 10.1177/1545968319860486] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
14 Eldridge S, Guo L, Hamre J 3rd. A Comparative Review of Chemotherapy-Induced Peripheral Neuropathy in In Vivo and In Vitro Models. Toxicol Pathol 2020;48:190-201. [PMID: 31331249 DOI: 10.1177/0192623319861937] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 7.3] [Reference Citation Analysis]
15 Kishimoto S, Oshima N, Rinker M, Krishna MC, Takebe N. Identification of high-risk drugs related to chemotherapy-induced peripheral neuropathy in Cancer Therapy Evaluation Program-sponsored phase I trials. Eur J Cancer 2019;115:111-9. [PMID: 31132741 DOI: 10.1016/j.ejca.2019.04.023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
16 Blair TF, Lambert K, Muzaffar M. Eribulin-Associated Foot Drop. Am J Ther 2019;26:e720-2. [PMID: 30570505 DOI: 10.1097/MJT.0000000000000881] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
17 Liu Y, May BH, Zhang AL, Guo X, Lu C, Xue CC, Zhang H. Integrative Herbal Medicine for Chemotherapy-Induced Peripheral Neuropathy and Hand-Foot Syndrome in Colorectal Cancer: A Systematic Review and Meta-Analysis. Integr Cancer Ther 2019;18:1534735418817833. [PMID: 30526124 DOI: 10.1177/1534735418817833] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
18 Brown MRD, Farquhar-Smith WP. Cannabinoids and cancer pain: A new hope or a false dawn? Eur J Intern Med 2018;49:30-6. [PMID: 29482740 DOI: 10.1016/j.ejim.2018.01.020] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
19 Teixeira Farinha H, Grass F, Labgaa I, Pache B, Demartines N, Hübner M. Inflammatory Response and Toxicity After Pressurized IntraPeritoneal Aerosol Chemotherapy. J Cancer 2018;9:13-20. [PMID: 29290765 DOI: 10.7150/jca.21460] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
20 Segat GC, Manjavachi MN, Matias DO, Passos GF, Freitas CS, Costa R, Calixto JB. Antiallodynic effect of β-caryophyllene on paclitaxel-induced peripheral neuropathy in mice. Neuropharmacology 2017;125:207-19. [PMID: 28729222 DOI: 10.1016/j.neuropharm.2017.07.015] [Cited by in Crossref: 61] [Cited by in F6Publishing: 62] [Article Influence: 10.2] [Reference Citation Analysis]
21 Kerckhove N, Pereira B, Pezet D, Balayssac D. Clinical assessment of new antineuropathic strategies for chemotherapy-induced peripheral neuropathy: pain should not be the principal endpoint. Pain 2017;158:180-2. [PMID: 27984530 DOI: 10.1097/j.pain.0000000000000743] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
22 Han CH, Kilfoyle DH, Hill AG, Jameson MB, McKeage MJ. Preventing oxaliplatin-induced neurotoxicity: rationale and design of phase Ib randomized, double-blind, placebo-controlled, cross-over trials for early clinical evaluation of investigational therapeutics. Expert Opin Drug Metab Toxicol 2016;12:1479-90. [PMID: 27539508 DOI: 10.1080/17425255.2016.1223625] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
23 Cascella M, Cuomo A, Viscardi D. Pain Syndromes Associated with Cancer Therapy. Features and Management of the Pelvic Cancer Pain 2016. [DOI: 10.1007/978-3-319-33587-2_3] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
24 Schloss J, Colosimo M, Vitetta L. New Insights into Potential Prevention and Management Options for Chemotherapy-Induced Peripheral Neuropathy. Asia Pac J Oncol Nurs 2016;3:73-85. [PMID: 27981142 DOI: 10.4103/2347-5625.170977] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]